drugset / Trial / NCT02202226
Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the tolerability and safety of Lu AF35700 after repeated oral dosing to patients with schizophrenia.
Timeline
- Start
- 2013-01
- Primary completion
- 2015-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AF35700 | Unknown | 5 mg | Oral |
| Subject | Lu AF35700 | Unknown | 30 mg | Oral |
| Subject | Lu AF35700 | Unknown | 75 mg | Oral |